IL37 and colorectal carcinoma: Using immunohistochemical staining, we found that IL‐37 expression is reduced in CRC tissues and that the percentage of patients with high IL‐37 expression decreases with increasing TNM stage (Figure 1D), suggests that IL‐37 may play an inhibitory role in the development of CRC.